CEL SCI (CVM)

Crown Equity Holdings, Inc.: CRWENews Highlights: CVM, MORN 11/18/2009 11:48:08 Nov 18, 2009 (M2 PRESSWIRE via COMTEX News Network) -- Las Vegas CRWENews.com is pleased to announce a stock highlight on CEL-SCI Corporation (NYSE Amex: CVM), Morningstar, Inc. (Nasdaq: MORN) CEL-SCI Announces Start of First Clinical Study of Investigational LEAPS-H1N1 Treatment for Hospitalized H1N1 Infected Patients at Johns Hopkins University School of Medicine 11/18/2009 09:45:00 VIENNA, Va., Nov 18, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of... TheFortuneFinancial.com Progressive Review on F, HMA, JBL, FRE, TD and CVM 11/17/2009 06:55:20 NEW DELHI, INDIA, Nov 17, 2009 (MARKETWIRE via COMTEX News Network) -- TheFortuneFinancial.com provides the highest level of independent research and investment strategies with the sole purpose... Is Amendment of Previously Filed Paperwork a Sign That CEL-SCI is Expecting Something Big? 11/12/2009 07:30:01 LOS ANGELES, Nov 12, 2009 (BUSINESS WIRE) -- BioMedReports.Com, the news portal which covers Wall Street's biomedical sector and delivers financial and investment intelligence to a community... CEL-SCI Collaborators Present Data Suggesting That LEAPS Technology Has Ability to Modify Immune Response 11/09/2009 09:40:00 VIENNA, Va., Nov 09, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that Dr. Kenneth S. Rosenthal, Professor of Immunology and... More News